A
TNGX icon

AlphaQuest’s Tango Therapeutics TNGX Stock Holding History

AlphaQuest’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-375
Closed -$3.32K – 1901
2025
Q4 		$3.32K Sell
375
-711
-65% -$6.13K ﹤0.01% 2197
2025
Q3 		$9.12K Buy
+1,086
New +$7.35K ﹤0.01% 2169
2024
Q4 		– Sell
-10,885
Closed -$83.8K – 2014
2024
Q3 		$83.8K Buy
10,885
+10,182
+1,448% +$97.2K 0.01% 1323
2024
Q2 		$6.03K Sell
703
-11,258
-94% -$87K ﹤0.01% 1336
2024
Q1 		$95K Buy
+11,961
New +$128K 0.02% 828

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

AlphaQuest's TNGX Position: Q1 2026 in Review

AlphaQuest sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 375 shares — an estimated $3.32K sold.

AlphaQuest first reported a position in TNGX in Q1 2024 and held it in 5 quarters. The position peaked at $95K in Q1 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • AlphaQuest reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 375 Tango Therapeutics shares in Q1 2026, an estimated $3.32K.
  • AlphaQuest first reported a position in Tango Therapeutics in Q1 2024 and held it in 5 quarters.
  • AlphaQuest's Tango Therapeutics position peaked at $95K in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.